Investing.com - Merck reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €2.06 on revenue of €5.21B. Analysts polled by Investing.com anticipated EPS of €2.11 on revenue of €5.17B.
Merck shares are down 21% from the beginning of the year, still down 22.66% from its 52 week high of €231.50 set on December 30, 2021. They are under-performing the STOXX 600 which is down 8.89% from the start of the year.
Merck shares gained 2.75% in intra-day trade following the report.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings beat by Siemens Healthineers on February 3, who reported EPS of €0.55 on revenue of €5.07B, compared to forecasts EPS of €0.505 on revenue of €4.9B.
Bayer had beat expectations on Tuesday with first quarter EPS of €1.26 on revenue of €11.12B, compared to forecast for EPS of €1.01 on revenue of €10.45B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar